HIV news from aidsmap.com

The untapped potential of CD8 cells: how cellular immunity may be the key to an HIV cure
Several presentations at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US provided hope for the development of therapeutic vaccinations as well as T-cell and antibody therapies that could lead to long-term control or even a cure for HIV. It had been thought that HIV infection, especially long-term infection, exhausts the immune cells that normally fight infections, leading to a state of immune ‘senescence’ (premature ageing) and long-term, low-level inflammation.
>> Read more

GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
Popular GLP-1 weight-loss medications generally work well for people living with HIV, and they may improve liver, gut and cardiovascular health and reduce smoking, along with their well-known benefits for obesity and diabetes, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2026). However, much remains to be learned about their long-term use.
>> Read more

Younger, mobile men especially likely to not know they have HIV in eastern and southern Africa
One in seven men living with HIV in eastern and southern Africa are unaware that they have the virus, according to research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US by Dr Craig Heck of Columbia University. Younger men and those who sometimes live away from home were more likely not to know their status.
>> Read more